Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.45 USD | +19.95% | +19.92% | +11.85% |
Sales 2024 * | - | Sales 2025 * | 44.94M 61.39M | Capitalization | 1.27B 1.73B |
---|---|---|---|---|---|
Net income 2024 * | -57M -77.86M | Net income 2025 * | -30M -40.98M | EV / Sales 2024 * | - |
Net cash position 2024 * | 139M 190M | Net cash position 2025 * | 99.6M 136M | EV / Sales 2025 * | 26 x |
P/E ratio 2024 * |
-24.2
x | P/E ratio 2025 * |
-50.3
x | Employees | 33 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.79% |
Latest transcript on Soleno Therapeutics, Inc.
1 day | +20.04% | ||
1 week | +19.92% | ||
Current month | +5.19% | ||
1 month | +8.51% | ||
3 months | -6.19% | ||
6 months | +94.47% | ||
Current year | +11.85% |
Managers | Title | Age | Since |
---|---|---|---|
Anish Bhatnagar
CEO | Chief Executive Officer | 56 | 05-12-31 |
James Mackaness
DFI | Director of Finance/CFO | 60 | 19-11-13 |
Ernest Mario
CHM | Chairman | 85 | 07-08-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ernest Mario
CHM | Chairman | 85 | 07-08-02 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 19-04-25 |
Bill Harris
BRD | Director/Board Member | 65 | 14-06-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 45.04 | +18.88% | 2 958 289 |
24-04-26 | 37.89 | +1.47% | 138,612 |
24-04-25 | 37.34 | -5.08% | 269,361 |
24-04-24 | 39.34 | -1.99% | 335,907 |
24-04-23 | 40.14 | +6.93% | 416,661 |
Delayed Quote Nasdaq, April 29, 2024 at 03:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.85% | 1.27B | |
-2.58% | 103B | |
+1.50% | 95.28B | |
+1.46% | 22.15B | |
-15.73% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.18% | 13.68B | |
+33.45% | 12.17B |
- Stock Market
- Equities
- SLNO Stock